Aoxin Q&M Dental Group Limited is an investment holding company and a leading provider of private dental healthcare services, dental laboratory services, and dental equipment and consumables distribution in the People's Republic of China. Founded in 1997 and headquartered in Shenyang, Liaoning Province, China, the company operates primarily in northern China and functions as a subsidiary of Singapore-based Q & M Dental Group (Singapore) Limited. The company structures its operations into three core business segments: Primary Dental Services, Dental Laboratory Services, and Distribution of Dental Equipment and Supplies.
Through its Primary Dental Services segment, the company operates a network of dental hospitals and polyclinics delivering general and specialized dental care, including general dentistry such as scaling, fillings, root canal therapy, and tooth extractions; restorative treatments and prosthodontics; dental implantology and oral and maxillofacial surgeries; orthodontics and malocclusion correction utilizing traditional fixed appliances and clear aligner therapies; cosmetic and aesthetic dentistry, including composite veneers and teeth whitening; and specialized paediatric dental services. Through its Dental Laboratory Services segment, the company designs, fabricates, and sells customized dental prostheses and appliances, including porcelain-fused-to-metal and all-ceramic crowns; zirconia bridges; full and partial removable dentures; orthodontic retainers; and computer-aided design and manufacturing (CAD/CAM) surgical guides. Through its Distribution of Dental Equipment and Supplies segment, the company distributes medical and dental devices, clinical instruments, diagnostic imaging equipment, and dental consumable supplies to third-party hospitals, dental polyclinics, and private practitioners.
In recent developments, Aoxin Q&M Dental Group has accelerated the digitalization of its dental healthcare operations and laboratory manufacturing pipelines, deploying digital intraoral scanning systems, 3D printing technologies, and automated CAD/CAM milling infrastructure across its network to enhance diagnostic accuracy and shorten prosthetic fabrication cycles. The company has completed post-pandemic operational realignments by refocusing corporate resources on core clinical dentistry and expanding dedicated paediatric and orthodontic treatment suites within its flagship hospitals. In addition, the group has deepened supply chain synergies with parent company Q & M Dental Group (Singapore) Limited to optimize equipment procurement costs and expanded the service capacity of its established clinics across Tier-2 and Tier-3 urban markets in Liaoning Province.